AzTrials
AzTrials

Posterior Atrophic MandibleNCT04590339

Lateralization of the Inferior Alveolar Nerve After Repositioning of the Bone Window Versus Sticky Bone Augmentation

A study testing Guided inferior Alveolar Nerve lateralization in people with Posterior Atrophic Mandible and Inferior Alveolar Nerve, run by Alexandria University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Rehabilitation of edentulous posterior mandibular regions with severe ridge atrophy using implants is subject to anatomical, surgical, and biological difficulties. In many cases, the bone is severely atrophied that sufficiently long fixtures cannot be placed without encroaching on the inferior alveolar nerve (IAN). Read more about this study

Who is it for?
Ages 25 to 60 yearsHealthy volunteers can take part
What is being tested?
Guided inferior Alveolar Nerve lateralization
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
25 Oct 2018to 10 Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients suffering from unilateral posterior mandibular edentulism and having < 8 mm of bone above the mandibular canal.
  • The width of the ridge should be > 4mm.
  • The patient should be psychologically accepting the implant and the involved procedures.
  • The patients should have adequate oral hygiene and adequate bone quality.

Who cannot join

  • Any absolute contraindication for implant surgery such as uncontrolled diabetes mellitus, blood and/or bleeding disorders, serious osseous defects…etc.
  • Any relevant systemic disease directly affecting bone metabolism and healing.
  • Any habits that might reduce the blood flow and retard healing such as heavy smoking and alcoholism.
  • A history of any grafting procedure at the designated area.
  • Patient with thick cortical bone buccally and a thin neurovascular bundle.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Dina Metawie

    Alexandria, 21500

Other trials in Egypt

About this study

Official title: Lateralization of the Inferior Alveolar Nerve After Repositioning of the Bone Window Versus Sticky Bone Augmentation: A Randomized Controlled Clinical Trial

Rehabilitation of edentulous posterior mandibular regions with severe ridge atrophy using implants is subject to anatomical, surgical, and biological difficulties. In many cases, the bone is severely atrophied that sufficiently long fixtures cannot be placed without encroaching on the inferior alveolar nerve (IAN). IANL is defined as the lateralization of inferior alveolar neurovascular bundle posterior to the mental foramen, with preservation of the incisive nerve; exposure and traction are used to deflect the IAN laterally while the implants are placed.

Read the detailed description

This prospective randomized clinical trial will enroll 20 patients with posterior mandibular ridge atrophy. Ten of which will undergo computer guided nerve lateralization with subsequent implant placement and repositioning of the osteomotized bone window and ten patients will undergo computer guided nerve lateralization with subsequent implant placement and sticky bone grafting.

Being tested
Guided inferior Alveolar Nerve lateralization
Keywords
inferior Alveolar nerve lateralization, neurosensory disturbance, guided surgery, Posterior atrophic mandibular ridge

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Guided inferior Alveolar Nerve lateralizationProcedure or surgery

    Also called computer guided implant placement

    Evaluating neurosensory recovery after Implant placement in posterior atrophic mandible by Guided inferior alveolar nerve lateralization technique

Study groups in NCT04590339
Study groupRoleWhat they receive
Repositioning the bone windowActive comparatorComputer guided inferior alveolar nerve lateralization and implant placement with subsequent repositioning of the osteotomized bone window.
Receives: Procedure: Guided inferior Alveolar Nerve lateralization
Augmentation using sticky boneActive comparatorComputer guided inferior alveolar nerve lateralization and implant placement with grafting around the implant using sticky bone
Receives: Procedure: Guided inferior Alveolar Nerve lateralization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in neurosensory recovery and sensation regaining over 6 months compared to normal (taken at base line)

    Electrophysiological test using Mental nerve Blink reflex is done for each patient before surgery(base line), after surgery at 1 month, 3 months and 6 months.

    Measured: 1 month, 3 months and 6 months

  2. Clinical assessment of the change in neurosensory function recovery using Static light touch detection test.

    Done at 1 week, 1 month, 3 months and 6 months postoperative.

    Measured: 1 week, 1 month, 3 months and 6 months

  3. Clinical assessment of the change in neurosensory function recovery using Brush stroke discrimination test.

    Done at 1 week, 1 month, 3 months and 6 months postoperative.

    Measured: 1 week, 1 month, 3 months and 6 months

  4. Clinical assessment of the change in neurosensory function recovery using two point discrimination test

    Done at 1 week, 1 month, 3 months and 6 months postoperative.

    Measured: 1 week, 1 month, 3 months and 6 months

  5. Clinical assessment of the change in neurosensory function recovery using pin-prick sensation test.

    Done at 1 week, 1 month, 3 months and 6 months postoperative.

    Measured: 1 week, 1 month, 3 months and 6 months

Secondary outcomes (1)
  1. Implant Success rate

    Implant Stability using osstell device to measure the implant success at the time of implant insertion, after 3 month and at 6 month.

    Measured: 3 months and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Oct 2020
  2. Study start25 Oct 2018
  3. Primary completion10 Dec 2020
  4. Study completion10 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04590339
Sponsor's protocol ID
0010556-IORG 00088390
Status last verified
Jul 2021
First submitted
12 Aug 2020
Last updated
28 Jul 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Guided inferior Alveolar Nerve lateralization in people with Posterior Atrophic Mandible and Inferior Alveolar Nerve, run by Alexandria University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in neurosensory recovery and sensation regaining over 6 months compared to normal (taken at base line) (time frame: 1 month, 3 months and 6 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in